| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bicalutamide | FIMM | pan-cancer | AAC | 0.087 | 0.6 |
| mRNA | ZSTK474 | GDSC1000 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | ciclosporin | CTRPv2 | pan-cancer | AAC | -0.022 | 0.6 |
| mRNA | ZSTK474 | CTRPv2 | pan-cancer | AAC | 0.023 | 0.6 |
| mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.023 | 0.6 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | 0.022 | 0.6 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | -0.025 | 0.6 |
| mRNA | BIRB 0796 | FIMM | pan-cancer | AAC | 0.087 | 0.6 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | 0.028 | 0.6 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | -0.022 | 0.6 |